Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostic Products Corporation adds Axis-Shield's anti-CCP test for rheumatoid arthritis to Immulite menu:

This article was originally published in Clinica

Executive Summary

Anglo-Norwegian IVD company Axis-Shield has agreed to license its anti-CCP test to Diagnostic Products Corporation (DPC) for use on the latter's Immulite chemiluminescent analyser to detect rheumatoid arthritis. Financial details of the agreement were not disclosed. The anti-CCP assay is considered to be the most significant breakthrough in the early diagnosis of rheumatoid arthritis, a condition that affects over 2 million people in the US alone, said Axis-Shield.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050600

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel